Skip to main content

6 Result(s)

within Y Fløisand Remove this filter

and

  1. No Access

    Article

    HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation

    B. Grønvold, M. M. Ali, M. Remberger, J. Mattsson… in Bone Marrow Transplantation (2020)

  2. Article

    Open Access

    The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors

    The effect of CD34+ cell dose in allogeneic hematopoietic stem cell transplantation (HSCT) on overall survival (OS) and incidence of acute and chronic graft-versus-host disease (GvHD) has not been established and...

    M. Remberger, B. Grønvold, M. Ali, J. Mattsson… in Clinical Hematology International (2020)

    Download PDF (621 KB)

  3. No Access

    Article

    Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice

    Multiple myeloma (MM) is a plasma cell malignancy where MM cell growth is supported by the bone marrow (BM) microenvironment with poorly defined cellular and molecular mechanisms. MM cells express CD40, a rece...

    D Wang, Y Fløisand, C V Myklebust, S Bürgler, A Parente-Ribes, P O Hofgaard… in Leukemia (2017)

  4. No Access

    Article

    HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

    Inhibitors of B-cell lymphoma-2 (BCL-2) such as venetoclax (ABT-199) and navitoclax (ABT-263) are clinically explored in several cancer types, including acute myeloid leukemia (AML), to selectively induce apop...

    M Kontro, A Kumar, M M Majumder, S Eldfors, A Parsons, T Pemovska, J Saarela… in Leukemia (2017)

  5. No Access

    Article

    Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT

    Chronic GVHD (cGVHD) associated bronchiolitis obliterans syndrome (BOS) is a serious complication after allo-SCT, and lung transplantation (LTx) may be the ultimate treatment option. To evaluate this treatment...

    A M Holm, G C Riise, L Hansson, L Brinch, Ø Bjørtuft… in Bone Marrow Transplantation (2013)

  6. No Access

    Article

    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation

    Reduced-intensity conditioning (RIC) allo-SCT is a potentially curative treatment approach for patients with relapsed Hodgkin’s or non-Hodgkin’s lymphoma. In the present study, 37 patients underwent RIC allo-S...

    Y Fløisand, L Brinch, T Gedde-Dahl, G E Tjønnfjord… in Bone Marrow Transplantation (2012)